col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


152 Results       Page 1

 [1] 
Elsevier: Cell Reports
  original article Date Title Authors   All Authors
1 [GO] 2022―May―16 IgG targeting distinct seasonal coronavirus OC43-conserved SARS-CoV-2 spike subdomains correlate with differential COVID-19 disease outcomes Jose L. Garrido, Matías A. Medina, Felipe Bravo, Sarah McGee, Francisco Fuentes-Villalobos, Mario Calvo, et al. (+6)
2 [GO] 2022―May―16 Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants by Modular, Tetravalent, Bi-paratopic Antibodies Shane Miersch, Nitin Sharma, Reza Saberianfar, Chao Chen, Francesca Caccuri, Alberto Zani, et al. (+6)
3 [GO] 2022―May―08 Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron Siling Wang, Hui Sun, Yali Zhang, Lunzhi Yuan, Yizhen Wang, Tianying Zhang, et al. (+20)
4 [GO] 2022―May―08 Longitudinal analyses reveal distinct immune response landscapes in lung and intestinal tissues from SARS-CoV-2-infected rhesus macaques Huiwen Zheng, Yanli Chen, Jing Li, Heng Li, Xin Zhao, Jiali Li, et al. (+10)
5 [GO] 2022―Apr―29 Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant Yang Liu, Jianying Liu, Bryan A. Johnson, Hongjie Xia, Zhiqiang Ku, Craig Schindewolf, et al. (+6)
6 [GO] 2022―Apr―26 Characterization and functional interrogation of the SARS-CoV-2 RNA interactome Athéna Labeau, Luc Fery-Simonian, Alain Lefevre-Utile, Marie Pourcelot, Lucie Bonnet-Madin, Vassili Soumelis, et al. (+4)
7 [GO] 2022―Apr―25 LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang, Denisa Foster, Peter Vaillancourt, Matthew Wiggin, et al. (+63)
8 [GO] 2022―Apr―21 Nasally-delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron Zhenlu Chong, Courtney E. Karl, Peter J. Halfmann, Yoshihiro Kawaoka, Emma S. Winkler, Shamus P. Keeler, et al. (+3)
9 [GO] 2022―Apr―19 Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry Enya Qing, Pengfei Li, Laura Cooper, Sebastian Schulz, Hans-Martin Jäck, Lijun Rong, et al. (+2)
10 [GO] 2022―Apr―15 SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination Prerna Arora, Amy Kempf, Inga Nehlmeier, Luise Graichen, Martin S. Winkler, Martin Lier, et al. (+7)
11 [GO] 2022―Apr―15 ChAdOx1 nCoV-19 (AZD1222) vaccine elicits monoclonal antibodies with potent cross-neutralizing activity against SARS-CoV-2 viral variants Jeffrey Seow, Carl Graham, Sadie R. Hallett, Thomas Lechmere, Thomas J.A. Maguire, Isabella Huettner, et al. (+12)
12 [GO] 2022―Apr―11 Structural and functional impact by SARS-CoV-2 Omicron spike mutations Jun Zhang, Yongfei Cai, Christy L. Lavine, Hanqin Peng, Haisun Zhu, Krishna Anand, et al. (+12)
13 [GO] 2022―Apr―09 Dynamic Ca2+ sensitivity stimulates the evolved SARS-CoV-2 spike strain-mediated membrane fusion for enhanced entry Puspangana Singh, Shreya Mukherji, Swarnendu Basak, Markus Hoffmann, Dibyendu Kumar Das
14 [GO] 2022―Apr―04 Humanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infection Devin J. Kenney, Aoife K. O’Connell, Jacquelyn Turcinovic, Paige Montanaro, Ryan M. Hekman, Tomokazu Tamura, et al. (+30)
15 [GO] 2022―Mar―25 mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron Hye Kyung Lee, Ludwig Knabl, Juan I. Moliva, Ludwig Knabl, Anne P. Werner, Seyhan Boyoglu-Barnum, et al. (+6)
16 [GO] 2022―Mar―07 Cross-species tropism and antigenic landscapes of circulating SARS-CoV-2 variants Yali Zhang, Min Wei, Yangtao Wu, Juan Wang, Yuting Hong, Yang Huang, et al. (+26)
17 [GO] 2022―Mar―07 Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting Blake M. Hauser, Maya Sangesland, Kerri J. St. Denis, Evan C. Lam, James Brett Case, Ian W. Windsor, et al. (+7)
18 [GO] 2022―Feb―22 SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract Frederick Hansen, Kimberly Meade-White, Chad Clancy, Rebecca Rosenke, Atsushi Okumura, David W. Hawman, et al. (+5)
19 [GO] 2022―Feb―21 Limited Extent and Consequences of Pancreatic SARS-CoV-2 Infection Verena van der Heide, Sonia Jangra, Phillip Cohen, Raveen Rathnasinghe, Sadaf Aslam, Teresa Aydillo, et al. (+19)
20 [GO] 2022―Feb―21 SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells Quirin Hammer, Josefine Dunst, Wanda Christ, Francesca Picarazzi, Mareike Wendorff, Pouria Momayyezi, et al. (+20)
21 [GO] 2022―Feb―21 BCG vaccination provides protection against IAV but not SARS-CoV-2 Eva Kaufmann, Nargis Khan, Kim A. Tran, Antigona Ulndreaj, Erwan Pernet, Ghislaine Fontes, et al. (+18)
22 [GO] 2022―Feb―08 SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between doses Debashree Chatterjee, Alexandra Tauzin, Lorie Marchitto, Shang Yu Gong, Marianne Boutin, Catherine Bourassa, et al. (+26)
23 [GO] 2022―Feb―07 Cryo-EM structure of the SARS-CoV-2 omicron spike Gabriele Cerutti, Yicheng Guo, Lihong Liu, Liyuan Liu, Zhening Zhang, Yang Luo, et al. (+5)
24 [GO] 2022―Feb―01 Follicular T Cells Optimize the Germinal Center Response to SARS-CoV-2 Protein Vaccination in Mice Cecilia B. Cavazzoni, Benjamin L. Hanson, Manuel A. Podestà, Elsa D. Bechu, Rachel L. Clement, Hengcheng Zhang, et al. (+8)
25 [GO] 2022―Jan―31 Long-term, infection-acquired immunity against the SARS-CoV-2 Delta variant in a hamster model Peter J. Halfmann, Makoto Kuroda, Tammy Armbrust, Molly Accola, Riccardo Valdez, Theresa Kowalski-Dobson, et al. (+3)
26 [GO] 2022―Jan―31 B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination Prasanti Kotagiri, Federica Mescia, William M. Rae, Laura Bergamaschi, Zewen K. Tuong, Lorinda Turner, et al. (+14)
27 [GO] 2022―Jan―28 SARS-CoV-2 variants of concern display enhanced intrinsic pathogenic properties and expanded organ tropism in mouse models Bettina Stolp, Marcel Stern, Ina Ambiel, Katharina Hofmann, Katharina Morath, Lara Gallucci, et al. (+7)
28 [GO] 2022―Jan―25 A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection Guillaume Beaudoin-Bussières, Yaozong Chen, Irfan Ullah, Jérémie Prévost, William D. Tolbert, Kelly Symmes, et al. (+20)
29 [GO] 2022―Jan―20 SARS-CoV-2 mRNA Vaccine Induces Robust Specific and Cross-reactive IgG and Unequal Neutralizing Antibodies in Naïve and Previously Infected Recipients Tara M. Narowski, Kristin Raphel, Lily E. Adams, Jenny Huang, Nadja A. Vielot, Ramesh Jadi, et al. (+4)
30 [GO] 2022―Jan―20 Rapid Identification of Neutralizing Antibodies against SARS-CoV-2 Variants by mRNA Display Shiho Tanaka, C. Anders Olson, Christopher O. Barnes, Wendy Higashide, Marcos Gonzalez, Justin Taft, et al. (+9)
31 [GO] 2022―Jan―19 Maintenance of broad neutralising antibodies and memory B cells 12 months post-infection is predicted by SARS-CoV-2 specific CD4+ T cell responses Harikrishnan Balachandran, Chansavath Phetsouphanh, David Agapiou, Anurag Adhikari, Chaturaka Rodrigo, Mohamed Hammoud, et al. (+26)
32 [GO] 2022―Jan―19 Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway. Jie Zhou, Thomas P. Peacock, Jonathan C. Brown, Daniel H. Goldhill, Ahmed M.E. Elrefaey, Rebekah Penrice-Randal, et al. (+23)
33 [GO] 2022―Jan―11 Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drive rapid and potent immunogenicity capable of single-dose protection Kylie M. Konrath, Kevin Liaw, Yuanhan Wu, Xizhou Zhu, Susanne N. Walker, Ziyang Xu, et al. (+23)
34 [GO] 2021―Dec―28 Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19 Xiaojie Bi, Wei Liu, Xuan Ding, Shuang Liang, Yufen Zheng, Xiaoli Zhu, et al. (+26)
35 [GO] 2021―Dec―23 A Bivalent Nanoparticle Vaccine Exhibits Potent Cross-protection against the Variants of SARS-CoV-2 Yaochang Yuan, Xiantao Zhang, Ran Chen, Yuzhuang Li, Bolin Wu, Rong Li, et al. (+19)
36 [GO] 2021―Dec―22 SARS-CoV-2 reactive and neutralizing antibodies discovered by single cell sequencing of plasma cells and mammalian display Roy A. Ehling, Cédric R. Weber, Derek M. Mason, Simon Friedensohn, Bastian Wagner, Florian Bieberich, et al. (+14)
37 [GO] 2021―Dec―21 Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naïve and subjects recovered from COVID-19 Roberto Lozano-Rodríguez, Jaime Valentín-Quiroga, José Avendaño-Ortiz, Alejandro Martín-Quirós, Alejandro Pascual-Iglesias, Verónica Terrón, et al. (+21)
38 [GO] 2021―Dec―21 High Titer Neutralization of Mu and C.1.2 SARS-CoV-2 Variants by Vaccine-elicited Antibodies of Previously Infected Individuals Takuya Tada, Hao Zhou, Belinda M. Dcosta, Marie I. Samanovic, Amber Cornelius, Ramin S. Herati, et al. (+2)
39 [GO] 2021―Dec―21 Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies Claudia A. Jette, Alexander A. Cohen, Priyanthi N.P. Gnanapragasam, Frauke Muecksch, Yu E. Lee, Kathryn E. Huey-Tubman, et al. (+8)
40 [GO] 2021―Dec―18 The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance Izumi Kimura, Yusuke Kosugi, Jiaqi Wu, Jiri Zahradnik, Daichi Yamasoba, Erika P. Butlertanaka, et al. (+17)
41 [GO] 2021―Dec―17 Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection Karolin I. Wagner, Laura M. Mateyka, Sebastian Jarosch, Vincent Grass, Simone Weber, Kilian Schober, et al. (+26)
42 [GO] 2021―Dec―16 Two-step fitness selection for intra-host variations in SARS-CoV-2 Jiarui Li, Pengcheng Du, Lijiang Yang, Ju Zhang, Chuan Song, Danying Chen, et al. (+27)
43 [GO] 2021―Dec―15 Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of Concern Wenwei Li, Yaozong Chen, Jérémie Prévost, Irfan Ullah, Maolin Lu, Shang Yu Gong, et al. (+24)
44 [GO] 2021―Dec―10 HLA-A∗02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses Pavlo A. Nesterenko, Jami McLaughlin, Brandon L. Tsai, Giselle Burton Sojo, Donghui Cheng, Daniel Zhao, et al. (+17)
45 [GO] 2021―Dec―08 SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity M. Gordon Joyce, Wei-Hung Chen, Rajeshwer S. Sankhala, Agnes Hajduczki, Paul V. Thomas, Misook Choe, et al. (+54)
46 [GO] 2021―Dec―07 Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses Paul R. Wratil, Niklas A. Schmacke, Burak Karakoc, Alex Dulovic, Daniel Junker, Matthias Becker, et al. (+20)
47 [GO] 2021―Dec―04 Structural Analysis of Receptor Binding Domain Mutations in SARS-CoV-2 Variants of Concern that Modulate ACE2 and Antibody Binding Dhiraj Mannar, James W. Saville, Xing Zhu, Shanti S. Srivastava, Alison M. Berezuk, Steven Zhou, et al. (+5)
48 [GO] 2021―Dec―03 IFP35 as a promising biomarker and therapeutic target for the syndromes induced by SARS-CoV-2 or influenza virus Yang Yu, Na Xu, Qi Cheng, Fei Deng, Meiqin Liu, Airu Zhu, et al. (+21)
49 [GO] 2021―Nov―24 Anti-SARS-CoV-2 antibodies elicited by COVID-19mRNA vaccine exhibit a unique glycosylation pattern Inbal Farkash, Tali Feferman, Noy Cohen-Saban, Yahel Avraham, David Morgenstern, Grace Mayuni, et al. (+8)
50 [GO] 2021―Nov―24 Two-adjuvant multiantigen candidate vaccine induces superior protective immune responses against SARS-CoV-2 challenge Wenwen Jiang, Li Shi, Lukui Cai, Xiaoyu Wang, Jingyan Li, Heng Li, et al. (+6)
51 [GO] 2021―Nov―10 Contribution of autophagy machinery factors to HCV and SARS-CoV-2 replication organelle formation Woan-Ing Twu, Ji-Young Lee, Heeyoung Kim, Vibhu Prasad, Berati Cerikan, Uta Haselmann, et al. (+2)
52 [GO] 2021―Nov―03 SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a wide variety of tissues Matteo D’Antonio, Jennifer P. Nguyen, Timothy D. Arthur, Hiroko Matsui, Agnieszka D’Antonio-Chronowska, Kelly A. Frazer
53 [GO] 2021―Oct―22 Selective functional antibody transfer into the breastmilk after SARS-CoV-2 infection Krista M. Pullen, Caroline Atyeo, Ai-Ris Y. Collier, Kathryn J. Gray, Mandy B. Belfort, Douglas A. Lauffenburger, et al. (+2)
54 [GO] 2021―Oct―22 Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome Weifan Xu, Gaofeng Pei, Hongrui Liu, Xiaohui Ju, Jing Wang, Qiang Ding, Pilong Li
55 [GO] 2021―Oct―20 Monoclonal antibodies protect aged rhesus macaques from SARS-CoV-2-induced immune activation and neuroinflammation Anil Verma, Chase E. Hawes, Yashavanth Shaan Lakshmanappa, Jamin W. Roh, Brian A. Schmidt, Joseph Dutra, et al. (+17)
56 [GO] 2021―Oct―19 Stabilized Coronavirus Spike Stem Elicits a Broadly Protective Antibody Ching-Lin Hsieh, Anne P. Werner, Sarah R. Leist, Laura J. Stevens, Ester Falconer, Jory A. Goldsmith, et al. (+14)
57 [GO] 2021―Oct―19 Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain Gabriele Cerutti, Yicheng Guo, Pengfei Wang, Manoj S. Nair, Maple Wang, Yaoxing Huang, et al. (+9)
58 [GO] 2021―Oct―16 An Airway Organoid-Based Screen Identifies a Role for the HIF1α-Glycolysis Axis in SARS-CoV-2 Infection Xiaohua Duan, Xuming Tang, Manoj S. Nair, Tuo Zhang, Yunping Qiu, Wei Zhang, et al. (+8)
59 [GO] 2021―Oct―12 Mechanistic Insights into COVID-19 by Global Analysis of the SARS-CoV-2 3CLpro Substrate Degradome Isabel Pablos, Yoan Machado, Hugo C. Ramos de Jesus, Yasir Mohamud, Reinhild Kappelhoff, Cecilia Lindskog, et al. (+20)
60 [GO] 2021―Oct―09 Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBD John M. Errico, Haiyan Zhao, Rita E. Chen, Zhuoming Liu, James Brett Case, Meisheng Ma, et al. (+8)
61 [GO] 2021―Oct―09 Remdesivir overcomes the S861 roadblock in SARS-CoV-2 polymerase elongation complex Jiqin Wu, Haofeng Wang, Qiaojie Liu, Rui Li, Yan Gao, Xiang Fang, et al. (+5)
62 [GO] 2021―Oct―08 A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration Xilin Wu, Lin Cheng, Ming Fu, Bilian Huang, Linjing Zhu, Shijie Xu, et al. (+8)
63 [GO] 2021―Oct―06 In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential Brandon Lam, Yu Jui Kung, John Lin, Ssu-Hsueh Tseng, Ya Chea Tsai, Liangmei He, et al. (+9)
64 [GO] 2021―Sep―30 Role of miR-2392 in Driving SARS-CoV-2 Infection J. Tyson McDonald, Francisco Javier Enguita, Deanne Taylor, Robert J. Griffin, Waldemar Priebe, Mark R. Emmett, et al. (+42)
65 [GO] 2021―Sep―30 The N-terminal domain of SARS-CoV-2 nsp1 plays key roles in suppression of cellular gene expression and preservation of viral gene expression Aaron S. Mendez, Michael Ly, Angélica M. González-Sánchez, Ella Hartenian, Nicholas T. Ingolia, Jamie H. Cate, Britt A. Glaunsinger
66 [GO] 2021―Sep―28 Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses Bailey B. Banach, Gabriele Cerutti, Ahmed S. Fahad, Chen-Hsiang Shen, Matheus Oliveira De Souza, Phinikoula S. Katsamba, et al. (+28)
67 [GO] 2021―Sep―27 High affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines Kathryn A. Pape, Thamotharampillai Dileepan, Amanda J. Kabage, Daria Kozysa, Rodolfo Batres, Clayton Evert, et al. (+10)
68 [GO] 2021―Sep―27 Landscape of human antibody recognition of the SARS-CoV-2 Receptor Binding Domain Adam K. Wheatley, Phillip Pymm, Robyn Esterbauer, Melanie H. Dietrich, Wen Shi Lee, Damien Drew, et al. (+27)
69 [GO] 2021―Sep―21 A highly potent antibody effective against SARS-CoV-2 variants of concern Craig Fenwick, Priscilla Turelli, Laurent Perez, Céline Pellaton, Line Esteves-Leuenberger, Alex Farina, et al. (+24)
70 [GO] 2021―Sep―20 Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19 Dong-Min Kim, Yuri Kim, Jun-Won Seo, Jooyeon Lee, Uni Park, Na-Young Ha, et al. (+31)
71 [GO] 2021―Sep―17 Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes Nianping Liu, Chen Jiang, Pengfei Cai, Zhuoqiao Shen, Wujianan Sun, Hao Xu, et al. (+8)
72 [GO] 2021―Sep―16 Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition Kevin J. Kramer, Nicole V. Johnson, Andrea R. Shiakolas, Naveenchandra Suryadevara, Sivakumar Periasamy, Nagarajan Raju, et al. (+16)
73 [GO] 2021―Sep―15 Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity Maria Vono, Angela Huttner, Sylvain Lemeille, Paola Martinez-Murillo, Benjamin Meyer, Stephanie Baggio, et al. (+14)
74 [GO] 2021―Sep―08 Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies Claudia A. Jette, Alexander A. Cohen, Priyanthi N.P. Gnanapragasam, Frauke Muecksch, Yu E. Lee, Kathryn E. Huey-Tubman, et al. (+8)
75 [GO] 2021―Sep―08 A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease Stephanie Patchett, Zongyang Lv, Wioletta Rut, Miklos Bekes, Marcin Drag, Shaun K. Olsen, Tony T. Huang
76 [GO] 2021―Aug―27 Profiling CD8+ T Cell Epitopes of COVID-19 Convalescents Reveals Reduced Cellular Immune Responses to SARS-CoV-2 Variants Hang Zhang, Shasha Deng, Liting Ren, Peiyi Zheng, Xiaowen Hu, Tengchuan Jin, Xu Tan
77 [GO] 2021―Aug―17 Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2 Tanushree Dangi, Jacob Class, Nicole Palacio, Justin M. Richner, Pablo Penaloza-MacMaster
78 [GO] 2021―Aug―17 The nucleotide addition cycle of the SARS-CoV-2 polymerase Subhas Chandra Bera, Mona Seifert, Robert N. Kirchdoerfer, Pauline van Nies, Yibulayin Wubulikasimu, Salina Quack, et al. (+6)
79 [GO] 2021―Aug―13 Acute SARS-CoV-2 infection is associated with an increased abundance of bacterial pathogens, including Pseudomonas aeruginosa in the nose Nicholas S. Rhoades, Amanda N. Pinski, Alisha N. Monsibais, Allen Jankeel, Brianna M. Doratt, Isaac R. Cinco, et al. (+2)
80 [GO] 2021―Aug―10 One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening Irene M. Francino-Urdaniz, Paul J. Steiner, Monica B. Kirby, Fangzhu Zhao, Cyrus M. Haas, Shawn Barman, et al. (+6)
81 [GO] 2021―Aug―10 Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals Elaine C. Chen, Pavlo Gilchuk, Seth J. Zost, Naveenchandra Suryadevara, Emma S. Winkler, Carly R. Cabel, et al. (+16)
82 [GO] 2021―Aug―06 Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms Michael J. Peluso, Amelia N. Deitchman, Leonel Torres, Nikita S. Iyer, Sadie E. Munter, Christopher C. Nixon, et al. (+23)
83 [GO] 2021―Aug―04 Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals Daniel Lozano-Ojalvo, Carmen Camara, Eduardo Lopez-Granados, Pilar Nozal, Lucía del Pino-Molina, Yadira Bravo-Gallego, et al. (+26)
84 [GO] 2021―Jul―28 No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencing Nathan Smits, Jay Rasmussen, Gabriela O. Bodea, Alberto A. Amarilla, Patricia Gerdes, Francisco J. Sanchez-Luque, et al. (+9)
85 [GO] 2021―Jul―23 Systemic IL-15, IFN-γ and IP-10/CXCL10 Signature Associated with Effective Immune Response to SARS-CoV-2 in BNT162b2 mRNA Vaccine Recipients Cristina Bergamaschi, Evangelos Terpos, Margherita Rosati, Matthew Angel, Jenifer Bear, Dimitris Stellas, et al. (+9)
86 [GO] 2021―Jul―20 Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication Caroline G. Williams, Alexander S. Jureka, Jesus A. Silvas, Anthony M. Nicolini, Stacie A. Chvatal, Jared Carlson-Stevermer, et al. (+3)
87 [GO] 2021―Jul―20 Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding Jakob Trimpert, Kristina Dietert, Theresa C. Firsching, Nadine Ebert, Tran Thi Nhu Thao, Daria Vladimirova, et al. (+12)
88 [GO] 2021―Jul―17 Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome Weifan Xu, Gaofeng Pei, Hongrui Liu, Xiaohui Ju, Jing Wang, Qiang Ding, Pilong Li
89 [GO] 2021―Jul―10 Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice David R. Martinez, Alexandra Scha¨fer, Sarah R. Leist, Dapeng Li, Kendra Gully, Boyd Yount, et al. (+9)
90 [GO] 2021―Jul―10 An intranasal vaccine durably protects against SARS-CoV-2 variants in mice Ahmed O. Hassan, Swathi Shrihari, Matthew J. Gorman, Baoling Ying, Dansu Yaun, Saravanan Raju, et al. (+13)
91 [GO] 2021―Jul―07 A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations Federico Bertoglio, Viola Fühner, Maximilian Ruschig, Philip Alexander Heine, Leila Abassi, Thomas Klünemann, et al. (+35)
92 [GO] 2021―Jul―07 Generation of glucocorticoid resistant SARS-CoV-2 T-cells for adoptive cell therapy Rafet Basar, Nadima Uprety, Emily Ensley, May Daher, Kimberly Klein, Fernando Martinez, et al. (+28)
93 [GO] 2021―Jun―29 Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19 Jason Neidleman, Xiaoyu Luo, Ashley F. George, Matthew McGregor, Junkai Yang, Cassandra Yun, et al. (+8)
94 [GO] 2021―Jun―29 A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters Traci L. Bricker, Tamarand L. Darling, Ahmed O. Hassan, Houda H. Harastani, Allison Soung, Xiaoping Jiang, et al. (+10)
95 [GO] 2021―Jun―29 SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, Amy Kempf, Inga Nehlmeier, Luise Graichen, et al. (+9)
96 [GO] 2021―Jun―26 Antibody landscape against SARS-CoV-2 proteome reveals significant differences between non-structural/ accessory proteins and structural proteins Yang Li, Zhaowei Xu, Qing Lei, Dan-yun Lai, Hongyan Hou, He-wei Jiang, et al. (+19)
97 [GO] 2021―Jun―25 Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19 Yu Kaku, Takeo Kuwata, Hasan Md Zahid, Takao Hashiguchi, Takeshi Noda, Noriko Kuramoto, et al. (+23)
98 [GO] 2021―Jun―23 Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell Maritza Puray-Chavez, Kyle M. LaPak, Travis P. Schrank, Jennifer L. Elliott, Dhaval P. Bhatt, Megan J. Agajanian, et al. (+25)
99 [GO] 2021―Jun―22 Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects Madeleine F. Jennewein, Anna J. MacCamy, Nicholas R. Akins, Junli Feng, Leah J. Homad, Nicholas K. Hurlburt, et al. (+23)
100 [GO] 2021―Jun―11 Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4+ T cell help Jernej Pušnik, Enrico Richter, Bianca Schulte, Ramona Dolscheid-Pommerich, Christian Bode, Christian Putensen, et al. (+3)
101 [GO] 2021―Jun―08 Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA-peptidomics Adi Nagler, Shelly Kalaora, Chaya Barbolin, Anastasia Gangaev, Steven L.C. Ketelaars, Michal Alon, et al. (+13)
102 [GO] 2021―Jun―08 Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the variant of concern lineage B.1.1.7 Bo Meng, Steven A. Kemp, Guido Papa, Rawlings Datir, Isabella ATM. Ferreira, Sara Marelli, et al. (+22)
103 [GO] 2021―May―19 Direct Derivation of Human Alveolospheres for SARS-CoV-2 Infection Modeling and Drug Screening Toshiki Ebisudani, Shinya Sugimoto, Kei Haga, Akifumi Mitsuishi, Reiko Takai-Todaka, Masayuki Fujii, et al. (+9)
104 [GO] 2021―May―14 SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression. Artem Nemudryi, Anna Nemudraia, Tanner Wiegand, Joseph Nichols, Deann T. Snyder, Jodi F. Hedges, et al. (+6)
105 [GO] 2021―May―13 Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells Robert Parker, Thomas Partridge, Catherine Wormald, Rebeca Kawahara, Victoria Stalls, Maria Aggelakopoulou, et al. (+10)
106 [GO] 2021―May―09 Dynamics of B-cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19 Zachary Montague, Huibin Lv, Jakub Otwinowski, William S. DeWitt, Giulio Isacchini, Garrick K. Yip, et al. (+9)
107 [GO] 2021―May―03 METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection Na Li, Hui Hui, Bill Bray, Gwendolyn Michelle Gonzalez, Mark Zeller, Kristian G. Anderson, et al. (+5)
108 [GO] 2021―Apr―27 Hepatitis C Virus Drugs That Inhibit the SARS-CoV-2 Papain-Like Protease Synergize with Remdesivir to Suppress Viral Replication in Cell Culture Khushboo Bafna, Kris White, Balasubramanian Harish, Romel Rosales, Theresa A. Ramelot, Thomas B. Acton, et al. (+7)
109 [GO] 2021―Apr―27 Systematic Functional Analysis of SARS-CoV-2 Proteins Uncovers Viral Innate Immune Antagonists and Remaining Vulnerabilities Manuel Hayn, Maximilian Hirschenberger, Lennart Koepke, Rayhane Nchioua, Jan Hendrik Straub, Susanne Klute, et al. (+18)
110 [GO] 2021―Apr―24 Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2 Xiaojuan Zhou, Fengge Ma, Jun Xie, Meng Yuan, Yunqiao Li, Namir Shaabani, et al. (+18)
111 [GO] 2021―Apr―23 Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection Jessie J.-Y. Chang, Daniel Rawlinson, Miranda E. Pitt, George Taiaroa, Josie Gleeson, Chenxi Zhou, et al. (+10)
112 [GO] 2021―Apr―15 SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery Apoorva Mulay, Bindu Konda, Gustavo Garcia, Changfu Yao, Stephen Beil, Jaquelyn Mary Villalba, et al. (+12)
113 [GO] 2021―Apr―05 Hypoxic and pharmacological activation of HIFs inhibits SARS-CoV-2 infection of lung epithelial cells Peter AC. Wing, Thomas P. Keeley, Xiaodong Zhuang, Jeffrey Y. Lee, Maria Prange-Barczynska, Senko Tsukuda, et al. (+17)
114 [GO] 2021―Apr―03 SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization Markus Hoffmann, Lu Zhang, Nadine Krüger, Luise Graichen, Hannah Kleine-Weber, Heike Hofmann-Winkler, et al. (+7)
115 [GO] 2021―Apr―02 Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction Shiho Torii, Chikako Ono, Rigel Suzuki, Yuhei Morioka, Itsuki Anzai, Yuzy Fauzyah, et al. (+4)
116 [GO] 2021―Mar―31 Cell-type-specific immune dysregulation in severely ill COVID-19 patients Changfu Yao, Stephanie A. Bora, Tanyalak Parimon, Tanzira Zaman, Oren A. Friedman, Joseph A. Palatinus, et al. (+15)
117 [GO] 2021―Mar―23 Drug repurposing screens reveal cell-type specific entry pathways and FDA approved drugs active against SARS-Cov-2 Mark Dittmar, Jae Seung Lee, Kanupriya Whig, Elisha Segrist, Minghua Li, Brinda Kamalia, et al. (+9)
118 [GO] 2021―Mar―20 Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class Micah Rapp, Yicheng Guo, Eswar R. Reddem, Jian Yu, Lihong Liu, Pengfei Wang, et al. (+11)
119 [GO] 2021―Mar―19 Antiviral Drug Screen Identifies DNA-Damage Response Inhibitor as Potent Blocker of SARS-CoV-2 Replication Gustavo Garcia, Arun Sharma, Arunachalam Ramaiah, Chandani Sen, Arunima Purkayastha, Donald B. Kohn, et al. (+22)
120 [GO] 2021―Mar―18 Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies Nicola Cotugno, Alessandra Ruggiero, Francesco Bonfante, Maria Raffaella Petrara, Sonia Zicari, Giuseppe Rubens Pascucci, et al. (+39)
121 [GO] 2021―Mar―14 Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients Yang Li, Ming-liang Ma, Qing Lei, Feng Wang, Wei Hong, Dan-yun Lai, et al. (+22)
122 [GO] 2021―Mar―07 The impact of Spike mutations on SARS-CoV-2 neutralization Chloe Rees-Spear, Luke Muir, Sarah A. Griffith, Judith Heaney, Yoann Aldon, Jonne L. Snitselaar, et al. (+15)
123 [GO] 2021―Feb―26 Metabolic programs define dysfunctional immune responses in severe COVID-19 patients Elizabeth A. Thompson, Katherine Cascino, Alvaro A. Ordonez, Weiqiang Zhou, Ajay Vaghasia, Anne Hamacher-Brady, et al. (+20)
124 [GO] 2021―Feb―23 Use of convalescent serum reduces severity of COVID-19 in nonhuman primates Robert W. Cross, Abhishek N. Prasad, Viktoriya Borisevich, Courtney Woolsey, Krystle N. Agans, Daniel J. Deer, et al. (+4)
125 [GO] 2021―Feb―10 Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2 Romain Gasser, Marc Cloutier, Jérémie Prévost, Corby Fink, Éric Ducas, Shilei Ding, et al. (+14)
126 [GO] 2021―Feb―05 SARS-CoV-2 ORF9b Inhibits RIG-I-MAVS Antiviral Signaling by Interrupting K63-Linked Ubiquitination of NEMO Jing Wu, Yuheng Shi, Xiaoyan Pan, Shuang Wu, Ruixia Hou, Yong Zhang, et al. (+11)
127 [GO] 2021―Jan―26 Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2 Timothy A. Bates, Jules B. Weinstein, Scotland Farley, Hans C. Leier, William B. Messer, Fikadu G. Tafesse
128 [GO] 2021―Jan―26 The immunodominant and neutralization linear epitopes for SARS-CoV-2 Shuai Lu, Xi-xiu Xie, Lei Zhao, Bin Wang, Jie Zhu, Ting-rui Yang, et al. (+17)
129 [GO] 2021―Jan―22 Early induction of functional SARS-CoV-2 specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients Anthony T. Tan, Martin Linster, Chee Wah Tan, Nina Le Bert, Wan Ni Chia, Kamini Kunasegaran, et al. (+10)
130 [GO] 2021―Jan―14 MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells Xin Yin, Laura Riva, Yuan Pu, Laura Martin-Sancho, Jun Kanamune, Yuki Yamamoto, et al. (+10)
131 [GO] 2021―Jan―14 Enhancement versus Neutralization by SARS-CoV-2 Antibodies from A Convalescent Donor Associates with Distinct Epitopes on the Receptor-Binding Domain Yunjiao Zhou, Zezhong Liu, Shibo Li, Wei Xu, Qianqian Zhang, Israel T. Silva, et al. (+19)
132 [GO] 2020―Dec―26 D614G mutation alters SARS-CoV-2 spike conformation and enhances protease cleavage at the S1/S2 junction Sophie M-C. Gobeil, Katarzyna Janowska, Shana McDowell, Katayoun Mansouri, Robert Parks, Kartik Manne, et al. (+6)
133 [GO] 2020―Dec―17 Cell type-specific immune dysregulation in severely ill COVID-19 patients Changfu Yao, Stephanie A. Bora, Tanyalak Parimon, Tanzira Zaman, Oren A. Friedman, Joseph A. Palatinus, et al. (+15)
134 [GO] 2020―Dec―01 A soluble ACE2 microbody protein fused to a single immunoglobulin Fc domain is a potent inhibitor of SARS-CoV-2 Takuya Tada, Chen Fan, Jennifer S. Chen, Ramanjit Kaur, Kenneth A. Stapleford, Harry Gristick, et al. (+4)
135 [GO] 2020―Nov―19 The Roborovski dwarf hamster - a highly susceptible model for a rapid and fatal course of SARS-CoV-2 infection Jakob Trimpert, Daria Vladimirova, Kristina Dietert, Azza Abdelgawad, Dusan Kunec, Simon Dökel, et al. (+4)
136 [GO] 2020―Nov―13 The Human Leukocyte Antigen Class II Immunopeptidome of SARS-CoV-2 Spike Glycoprotein Michael D. Knierman, Megan B. Lannan, Laura J. Spindler, Carl L. McMillian, Robert J. Konrad, Robert W. Siegel
137 [GO] 2020―Nov―03 HSV-1 and Zika Virus but Not SARS-CoV-2 Replicate in the Human Cornea and Are Restricted by Corneal Type III Interferon Jonathan J. Miner, Derek J. Platt, Cyrus M. Ghaznavi, Pallavi Chandra, Andrea Santeford, Amber M. Menos, et al. (+6)
138 [GO] 2020―Oct―20 High-density amplicon sequencing identifies community spread and ongoing evolution of SARS-CoV-2 in the Southern United States Ryan P. McNamara, Carolina Caro-Vegas, Justin T. Landis, Razia Moorad, Linda J. Pluta, Anthony B. Eason, et al. (+19)
139 [GO] 2020―Oct―12 Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes Tongqing Zhou, I-Ting Teng, Adam S. Olia, Gabriele Cerutti, Jason Gorman, Alexandra Nazzari, et al. (+32)
140 [GO] 2020―Sep―29 An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain Nicholas C. Wu, Meng Yuan, Hejun Liu, Chang-Chun D. Lee, Xueyong Zhu, Sandhya Bangaru, et al. (+7)
141 [GO] 2020―Sep―23 Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects Ya-Wen Cheng, Tai-Ling Chao, Chiao-Ling Li, Mu-Fan Chiu, Han-Chieh Kao, Sheng-Han Wang, et al. (+11)
142 [GO] 2020―Sep―19 Evasion of type-I interferon by SARS-CoV-2 Hongjie Xia, Zengguo Cao, Xuping Xie, Xianwen Zhang, John Yun-Chung Chen, Hualei Wang, et al. (+3)
143 [GO] 2020―Sep―06 Activation of the SARS-CoV-2 receptor Ace2 through JAK/STAT-dependent enhancers during pregnancy Lothar Hennighausen, Hye Kyung Lee
144 [GO] 2020―Sep―04 SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant Yoriyuki Konno, Izumi Kimura, Keiya Uriu, Masaya Fukushi, Takashi Irie, Yoshio Koyanagi, et al. (+4)
145 [GO] 2020―Sep―03 A single-cell RNA expression map of human coronavirus entry factors Manvendra Singh, Vikas Bansal, Cédric Feschotte
146 [GO] 2020―Jul―24 A carbohydrate-binding protein from the edible Lablab beans effectively blocks the infections of influenza viruses and SARS-CoV-2 Yo-Min Liu, Md. Shahed-Al-Mahmud, Xiaorui Chen, Ting-Hua Chen, Kuo-Shiang Liao, Jennifer M. Lo, et al. (+6)
147 [GO] 2020―Jul―07 Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice. Andrea J. Pruijssers, Amelia S. George, Alexandra Schäfer, Sarah R. Leist, Lisa E. Gralinksi, Kenneth H. Dinnon, et al. (+23)
148 [GO] 2020―Jul―03 Potential causes and consequences of gastrointestinal disorders during a SARS-CoV-2 infection François Trottein, Harry Sokol
149 [GO] 2020―Jul―03 Human IgG neutralizing monoclonal antibodies block SARS-CoV-2 infection Jinkai Wan, Shenghui Xing, Longfei Ding, Yongheng Wang, Chenjian Gu, Yanling Wu, et al. (+20)
150 [GO] 2020―May―30 Structural and biochemical characterization of nsp12-nsp7-nsp8 core polymerase complex from SARS-CoV-2 Qi Peng, Ruchao Peng, Bin Yuan, Jingru Zhao, Min Wang, Xixi Wang, et al. (+6)
151 [GO] 2020―May―18 Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections Huibin Lv, Nicholas C. Wu, Owen Tak-Yin Tsang, Meng Yuan, Ranawaka A.P. M. Perera, Wai Shing Leung, et al. (+13)
152 [GO] 2020―May―08 Publishing in a Pandemic: The View from Cell Reports The Cell Reports Editorial Team
 [1] 

152 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.007 sec